Jaguar Health, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 07:43:45 15/07/2026 pm IST			5-day change	1st Jan Change
2.135 ^USD	-1.61%		-12.86%	-93.56%

25/06	Jaguar Health, Inc., Napo Pharmaceuticals, Inc., And Woodward Specialty LLC Amend Manufacturing And Supply Agreement	CI
24/06	Jaguar Health Initiates Strategic-Alternatives Review Ahead of Crofelemer NDA Filing for Rare Intestinal Failure Program	CI

Published on 11/17/2025 at 07:50 pm IST - Modified on 11/29/2025 at 02:53 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Greetings, and welcome to the Jaguar Health's Investor Webcast. [Operator Instructions] As a reminder, this conference is being recorded.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

25/06	Jaguar Health, Inc., Napo Pharmaceuticals, Inc., And Woodward Specialty LLC Amend Manufacturing And Supply Agreement	CI
24/06	Jaguar Health Initiates Strategic-Alternatives Review Ahead of Crofelemer NDA Filing for Rare Intestinal Failure Program	CI
23/06	Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy	MT
22/06	Jaguar Health Explores Strategic Alternatives	MT
09/06	Jaguar Health, Inc. announced that it expects to receive $41.99992 million in funding	CI
26/05	Jaguar Health, Inc., Q1 2026 Earnings Call, May 26, 2026
21/05	Jaguar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
10/04	Jaguar Health, Inc., Q4 2025 Earnings Call, Apr 10, 2026
07/04	Jaguar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
07/04	Jaguar Health, Inc. Auditor Raises 'Going Concern' Doubt	CI
18/02	Jaguar Health to Pay Special Stock Dividend	MT
16/01	Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing	RE
06/01	Jaguar Health, Inc. announced that it has received $0.35 million in funding	CI
24/11	Jaguar Health, Inc. announced that it has received $10.81 million in funding	CI
21/11	Jaguar Health's Napo Pharmaceuticals Submits Amended Crofelemer Trial Protocol to FDA	MT